Please login to the form below
patient enrolment
This page shows the latest patient enrolment news and features for those working in and with pharma, biotech and healthcare.
Tiziana’s foralumab shows continued clinical improvement in secondary progressive MS
Prior to this, in June 2022, the patient required a cane to walk this same distance. ... The company announced in November last year that it had completed the enrolment of the first patient cohort in its intermediate size patient population expanded
Latest news
-
Tiziana completes enrolment of first patient cohort in MS expanded access programme
Tiziana Life Sciences (Tiziana) has completed the enrolment of the first patient cohort in its intermediate size patient population expanded access programme to evaluate foralumab in non-active Secondary Progressive Multiple ... foralumab in this patient
-
Tiziana starts enrolment in secondary progressive MS expanded access programme
Tiziana Life Sciences (Tiziana) has announced the start of enrolment of the first patient cohort in its intermediate size patient population expanded access programme to evaluate foralumab in non-active secondary ... Given the strong feedback we’ve
-
Abivax enrols first patient in global phase 3 programme with obefazimod in ulcerative colitis
We are very happy that our pivotal global phase 3 programme has successfully started in the US with the enrolment of the first patient.
-
Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval
patient population for Aduhelm of approximately one to two million people, according to the companies. ... to address pricing in order to achieve both patient access and support budget sustainability.”.
-
RedHill Biopharma advances phase 2/3 COVID-19 programme
With the study now approved in the UK and Russia, and additional approvals expected in the coming weeks, patient enrolment is planned to commence later this month,” said Aida Bibliowicz, vice
More from news
Approximately 1 fully matching, plus 37 partially matching documents found.
Latest Intelligence
-
Navigating the patient experience to improve retention of clinical trial participants
While most of the focus is, rightly, on patient enrolment, we cannot forget the crucial element of patient retention in securing the viability of a clinical trial. ... On one hand, it is making it easier to build studies around patients’ needs,
-
Despite the rise of digital technology in clinical trials, community engagement has never been so important
patient enrolment and engagement. ... Sites have reported struggling to cope with such high enrolment demands with many admitting that studies are falling behind due to delays in patient recruitment.
-
Building a brighter future with patient support programmes
They are the multipurpose building blocks that improve patient safety, pharmacovigilance, trial enrolment and retention, disease management, adherence, market share and quality of life for patients. ... We run these programmes to create a better patient
-
How early-stage clinical research is facilitating the new wave of personalised medicines
One of these adaptations relates to patient enrolment. Whereas previously CROs were able to draw on a wide-ranging patient cohort for firstin-human studies, gene editing studies require a cohort ... to the target patient population and that adaptive
-
Transforming clinical trial data into a long-term asset
Having experienced the disruption caused by the pandemic, 51% identified a need for more diversification of patient enrolment, for instance, by expanding the scope of trials beyond just one city, country ... Trial data in a digitised world. As the role
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch. ... Developing a close relationship with your sites positively impacts patient recruitment targets in your clinical trials.
-
Key benefits of a digital patient recruitment solution
Why should you choose COUCH Health and our new digital patient recruitment software - TrialVerse? ... COUCH Health are market-leading experts on cultural safety in healthcare, and we can help you to increase patient enrolment from diverse and
-
Rare Disease Day – why it’s important to show your stripes
This collaborative model has proved highly successful, as demonstrated by the natural history registry ACCELERATE (recently published in Cell Reports Medicine); the patient-powered design enabled high enrolment and increased the ... Pharma and biotech
-
Can cultural safety training for sites improve diversity?
We wanted to understand exactly how the healthcare industry was perceived by people from ethnic minority backgrounds, so that we can begin to break down barriers in patient recruitment in these
-
New from the FDA: Diversity in clinical trials guidance summarised
The FDA provides key examples of how to improve study design and conduct to enhance enrolment:. ... Engage with patient advocacy groups, experts and patients, early on in the drug development process.
More from PMHub
Approximately 0 fully matching, plus 10 partially matching documents found.
Subscribe to our email news alerts
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- Decision date for Sarepta’s Duchenne muscular dystrophy gene therapy delayed by FDA
- Seqera Labs and Genomics England partner to progress genomic research
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s RSV vaccine approved by FDA for older adults
- Survey launch: The future of HCP engagement impact
- Engaging with patients will create more effective patient pathways
- Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer
No results were found
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
- Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
- Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- ...
